Is elidel still on the market?

Yes. Elidel (pimecrolimus) is still on the market in the U.S. and many other countries as a prescription treatment for atopic dermatitis (eczema).

Important safety notes:
- It carries a boxed warning about a potential increased risk of cancer (lymphomas and skin cancers) and infections with topical calcineurin inhibitors.
- It’s typically used for short-term or intermittent treatment of affected areas and is usually not first-line therapy.
- In the U.S., it’s approved for people 2 years and older; not typically used on large areas or broken skin unless advised by a clinician.
- Avoid use on infected skin and in certain other medical conditions; discuss pregnancy/breastfeeding and other medicines with your doctor.

If you tell me your country or region, I can give more specific and up-to-date availability and labeling details. If you’re considering this medicine, please consult a healthcare professional to review risks and benefits for your situation.